Prof Trau‘s Biomedical Innovation Lab transforms new ideas from the lab bench to products in the market. With a strong track record of spinning-off life science and biomedical companies such as AYOXXA, Tip Biosystems, E3A Healthcare and co-Founder/Inventor of ABYSS Processing and AVECRIS and supporting numerous other ventures, the lab made a big commercial impact and supporting the health system. The lab in collaboration with the AIT Entrepreneurship Center works closely with various companies to develop innovative products
Current Research
Synthetic Biology
Micro/Nanoencapsulation
Biosensors / Medical devices
Research Interest
Development of new approaches and platform technologies for bioanalytics, biosensors and diagnostics. By utilizing synergies within microfabrication, encapsulation technology, surface/colloidal chemistry and molecular biology novel analytical techniques and devices are created. Expert in analytical chemistry, colloidal chemistry and encapsulation. Major invention are “Reverse Phase LbL Encapsulation Technology“ to encapsulate macromolecular drugs (patents granted); “Microcapsule-PCR” to perform millions of PCRs in parallel (patents granted); “In-situ Encoded Bead Microarrays“ for protein multiplexing (patents granted); “Supernova biolabel technology“ for ultra-high sensitive bioassays (patents granted); “PHOTOPETTE handheld” and “SPECTROPOD microvolume” spectrophotometer technology enabling the first personal handheld spectrophotometer (patents granted) and “BiliOptics Sclera Scanner” for non-invasive jaundice diagnostics and management in infants. Patents are granted for most of Dr Trau’s technologies and commercialized by several companies including Capsulution GmbH and 8sens Biognostic GmbH in Germany, Supernova Ltd in Hong Kong and AYOXXA GmbH in Germany, E3A Healthcare and Tip Biosystems Pte Ltd in Singapore.
